Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
117M
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
29.9M
-
Shares change
-
+1.79M
-
Total reported value, excl. options
-
$842M
-
Value change
-
+$50.8M
-
Put/Call ratio
-
2.53
-
Number of buys
-
68
-
Number of sells
-
-54
-
Price
-
$28.15
Significant Holders of Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) as of Q4 2016
151 filings reported holding CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share as of Q4 2016.
Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.9M shares
of 117M outstanding shares and own 25.58% of the company stock.
Largest 10 shareholders include FMR LLC (6.55M shares), Kohlberg Kravis Roberts & Co. L.P. (3.06M shares), JPMORGAN CHASE & CO (1.56M shares), BlackRock Fund Advisors (1.56M shares), WELLINGTON MANAGEMENT GROUP LLP (1.24M shares), VANGUARD GROUP INC (1.17M shares), STATE STREET CORP (950K shares), ORBIMED ADVISORS LLC (850K shares), PRICE T ROWE ASSOCIATES INC /MD/ (845K shares), and BlackRock Institutional Trust Company, N.A. (740K shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.